Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

By Discontinuing Beta-Blockers Before an Exercise Test, We may Precipitate a Rebound Phenomenon

Author(s): Goran Koracevic, Sladjana Micic and Milovan Stojanovic*

Volume 19, Issue 6, 2021

Published on: 02 March, 2021

Page: [624 - 633] Pages: 10

DOI: 10.2174/1570161119666210302152322

Price: $65

Abstract

Background: There is a need to analyse the current approach to beta-blocker (BB) use in relation to exercise-based stress tests.

Objective: We compared various guidelines regarding recommending abrupt vs. gradual discontinuation of BB prior to exercise tests. We also analyse the shortcomings of the currently recommended approach and suggest a new approach to avoid BB rebound.

Methods: A narrative review is used to analyse this topic due to the lack of valid randomized clinical trials.

Results: Omitting the BB therapy prior to exercise-based test has been recommended in guidelines for many years. Although reasonable, this approach has potential disadvantages since sudden BB withdrawal may induce a rebound phenomenon, which is also acknowledged in several guidelines.

Conclusion: We observed inconsistency among relevant guidelines; there is no homogenous approach regarding BB use before exercise tests. Most guidelines recommend BB withdrawal for a couple of days before the test; they do not advise BB dose tapering. This approach is not standardised and raises the risk of BB rebound phenomenon before and during the test. Therefore, we suggest using half the prescribed BB dose at the usual time of administration (in the morning, prior to the exercise test).

Keywords: Beta-blocker, exercise test, rebound phenomenon, withdrawal syndrome, chronic coronary syndrome, oxygen supply.

« Previous Next »
Graphical Abstract

[1]
Rousan TA, Thadani U. Stable angina medical therapy management guidelines: a critical review of guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence. Eur Cardiol 2019; 14(1): 18-22.
[http://dx.doi.org/10.15420/ecr.2018.26.1] [PMID: 31131033]
[2]
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41(3): 407-77.
[http://dx.doi.org/10.1093/eurheartj/ehz425] [PMID: 31504439]
[3]
Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34(38): 2949-3003.
[http://dx.doi.org/10.1093/eurheartj/eht296] [PMID: 23996286]
[4]
Kociánová E, Václavík J, Tomková J, et al. Heart rate is a useful marker of adherence to beta-blocker treatment in hypertension. Blood Press 2017; 26(5): 311-8.
[http://dx.doi.org/10.1080/08037051.2017.1346458] [PMID: 28701047]
[5]
van Loon LM, van der Hoeven JG, Lemson J. Hemodynamic response to β-blockers in severe sepsis and septic shock: A review of current literature. J Crit Care 2019; 50: 138-43.
[http://dx.doi.org/10.1016/j.jcrc.2018.12.003] [PMID: 30540967]
[6]
Salem JE, Laveau F, Ceccaldi A, et al. Impact of negative inotropic drugs on accuracy of diastolic stress echocardiography for evaluation of left ventricular filling pressure. Sci Rep 2017; 7(1): 9537.
[http://dx.doi.org/10.1038/s41598-017-10301-5] [PMID: 28842666]
[7]
Miller AJ, Arnold AC. The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clin Auton Res 2019; 29(2): 231-43.
[http://dx.doi.org/10.1007/s10286-018-0572-5] [PMID: 30413906]
[8]
Telkova IL, Tepliakov AT. Relationships between changes of coronary blood flow, energy metabolism of the myocardium, and hyperinsulinemia in patients with ischemic heart disease. Kardiologiia 2005; 45(8): 61-8.
[PMID: 16091647]
[9]
Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999; 33(7): 2092-197.
[http://dx.doi.org/10.1016/S0735-1097(99)00150-3] [PMID: 10362225]
[10]
Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003; 41(1): 159-68.
[http://dx.doi.org/10.1016/S0735-1097(02)02848-6] [PMID: 12570960]
[11]
Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002; 40(8): 1531-40.
[http://dx.doi.org/10.1016/S0735-1097(02)02164-2] [PMID: 12392846]
[12]
Steeds RP, Wheeler R, Bhattacharyya S, et al. Stress echocardiography in coronary artery disease: a practical guideline from the British Society of Echocardiography. Echo Res Pract 2019; 6(2): G17-33.
[http://dx.doi.org/10.1530/ERP-18-0068] [PMID: 30921767]
[13]
Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012; 126(25): e354-471.
[PMID: 23166211]
[14]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6(7): e1000097.
[http://dx.doi.org/10.1371/journal.pmed.1000097] [PMID: 19621072]
[15]
Mancini GB, Gosselin G, Chow B, et al. Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease. Can J Cardiol 2014; 30(8): 837-49.
[http://dx.doi.org/10.1016/j.cjca.2014.05.013] [PMID: 25064578]
[16]
Fletcher GF, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards. A statement for health professionals from the American Heart Association. Circulation 1990; 82(6): 2286-322.
[http://dx.doi.org/10.1161/01.CIR.82.6.2286] [PMID: 2242557]
[17]
Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards. A statement for healthcare professionals from the American Heart Association. Circulation 1995; 91(2): 580-615.
[http://dx.doi.org/10.1161/01.CIR.91.2.580] [PMID: 7805272]
[18]
Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104(14): 1694-740.
[http://dx.doi.org/10.1161/hc3901.095960] [PMID: 11581152]
[19]
Sicari R. Anti-ischemic therapy and stress testing: pathophysiologic, diagnostic and prognostic implications. Cardiovasc Ultrasound 2004; 2: 14.
[http://dx.doi.org/10.1186/1476-7120-2-14] [PMID: 15320951]
[20]
Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 2007; 20(9): 1021-41.
[http://dx.doi.org/10.1016/j.echo.2007.07.003] [PMID: 17765820]
[21]
Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008; 9(4): 415-37.
[http://dx.doi.org/10.1093/ejechocard/jen175] [PMID: 18579481]
[22]
Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 2009; 30(3): 278-89.
[http://dx.doi.org/10.1093/eurheartj/ehn492] [PMID: 19001473]
[23]
Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 2013; 128(8): 873-934.
[http://dx.doi.org/10.1161/CIR.0b013e31829b5b44] [PMID: 23877260]
[24]
Fallahi B, Beiki D, Akbarpour S, et al. Withholding or continuing beta-blocker treatment before dipyridamole myocardial perfusion imaging for the diagnosis of coronary artery disease? A randomized clinical trial. Daru 2013; 21(1): 8.
[http://dx.doi.org/10.1186/2008-2231-21-8] [PMID: 23351617]
[25]
Shaw LJ, Xie JX, Phillips LM, et al. Optimising diagnostic accuracy with the exercise ECG: opportunities for women and men with stable ischaemic heart disease. Heart Asia 2016; 8(2): 1-7.
[http://dx.doi.org/10.1136/heartasia-2016-010736] [PMID: 27326241]
[26]
Sicari R, Cortigiani L. The clinical use of stress echocardiography in ischemic heart disease. Cardiovasc Ultrasound 2017; 15(1): 7.
[http://dx.doi.org/10.1186/s12947-017-0099-2] [PMID: 28327159]
[27]
Dancy L, O’Gallagher K, Milton P, Sado D. New NICE guidelines for the management of stable angina. Br J Gen Pract 2018; 68(669): 202-3.
[http://dx.doi.org/10.3399/bjgp18X695693] [PMID: 29592946]
[28]
Anagnostopoulos C, Harbinson M, Kelion A, et al. Procedure guidelines for radionuclide myocardial perfusion imaging. Heart 2004; 90(1)(Suppl. 1): i1-i10.
[http://dx.doi.org/10.1136/heart.90.suppl_1.i1] [PMID: 14676223]
[29]
Strauss HW, Miller DD, Wittry MD, et al. Procedure guideline for myocardial perfusion imaging 3.3. J Nucl Med Technol 2008; 36(3): 155-61.
[http://dx.doi.org/10.2967/jnmt.108.056465] [PMID: 18703619]
[30]
Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27(11): 1341-81.
[http://dx.doi.org/10.1093/eurheartj/ehl001] [PMID: 16735367]
[31]
Arumugam P, Harbinson M, Reyes E, et al. Procedure guidelines for radionuclide myocardial perfusion imaging with single-photon emission computed tomography. Nucl Med Commun 2013; 34(8): 813-26.
[http://dx.doi.org/10.1097/MNM.0b013e32836171eb] [PMID: 23719150]
[32]
Amorim BJ, Nesquita CT, Araujo EB, Kubo T, Nogueira S, Rivera M. Guideline for rest and stress myocardial perfusion scintigraphy. Int J Cardiovasc Sci 2016; 29(3): 243-7.
[http://dx.doi.org/10.5935/2359-4802.20160035]
[33]
Burkule N, Bansal M. Indian academy of echocardiography guidelines and manual for performance of stress echocardiography in coronary artery disease. J Indian Acad Echocardiogr Cardiovasc Imaging 2017; 1: 71-102.
[34]
Physiopathology and electrocardiography, Guidelines for cardiac exercise testing. Eur Heart J 1993; 14(7): 969-88.
[http://dx.doi.org/10.1093/eurheartj/14.7.969] [PMID: 8375424]
[35]
Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997; 30(1): 260-311.
[PMID: 9207652]
[36]
Koracevic G, Micic S, Stojanovic M, et al. Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies. Hypertens Res 2020; 43(7): 591-6.
[http://dx.doi.org/10.1038/s41440-020-0449-6] [PMID: 32382156]
[37]
Koraćević M, Lalić J, Nedeljković S, Koraćević G. Rebound Phenomenon – Important and Ubiquitous in Pharmacotherapy. Acta Medica Medianae 2018; 57(4): 148-52.
[http://dx.doi.org/10.5633/amm.2018.0420]
[38]
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39(33): 3021-104.
[http://dx.doi.org/10.1093/eurheartj/ehy339] [PMID: 30165516]
[39]
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34(28): 2159-219.
[http://dx.doi.org/10.1093/eurheartj/eht151] [PMID: 23771844]
[40]
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71(19): e127-248.
[http://dx.doi.org/10.1016/j.jacc.2017.11.006] [PMID: 29146535]
[41]
Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res 2019; 42(9): 1235-481.
[http://dx.doi.org/10.1038/s41440-019-0284-9] [PMID: 31375757]
[42]
National Heart Foundation of Australia. Guidelines for the diagnosis and management of hypertension in adults 2016. Available at: www.heartfoundation.org.au/getmedia/c83511ab-835a-4fcf-96f5-88d770582ddc/PRO-167_Hypertension-guideline-2016_WEB.pdf
[43]
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37(27): 2129-200.
[http://dx.doi.org/10.1093/eurheartj/ehw128] [PMID: 27206819]
[44]
Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128(16): e240-327.
[http://dx.doi.org/10.1161/CIR.0b013e31829e8776] [PMID: 23741058]
[45]
North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management angina. BMJ 1996; 312(7034): 827-32.
[http://dx.doi.org/10.1136/bmj.312.7034.827] [PMID: 8608294]
[46]
Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014; 64(22): e77-e137.
[http://dx.doi.org/10.1016/j.jacc.2014.07.944] [PMID: 25091544]
[47]
Schalant RC, Gunnar BC, Branderburg RO, et al. Guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommitte on Exercise Testing). J Am Coll Cardiol 1986; 8(3): 725-38.
[PMID: 2943787]
[48]
Khan MA, Hashim MJ, Mustafa H, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus 2020; 12(7): e9349.
[http://dx.doi.org/10.7759/cureus.9349] [PMID: 32742886]
[49]
Imori Y, Takano H, Mase H, et al. Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy. BMC Cardiovasc Disord 2019; 19(1): 316.
[http://dx.doi.org/10.1186/s12872-019-01274-6] [PMID: 31888491]
[50]
Younis A, Orvin K, Nof E, et al. The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement. Catheter Cardiovasc Interv 2019; 93(7): 1361-6.
[http://dx.doi.org/10.1002/ccd.28017] [PMID: 30489692]
[51]
de Lucia C, Eguchi A, Koch WJ. New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging. Front Pharmacol 2018; 9: 904.
[http://dx.doi.org/10.3389/fphar.2018.00904] [PMID: 30147654]
[52]
Maccari S, Vezzi V, Barbagallo F, et al. β-blockers Reverse Agonist-Induced β2-AR Downregulation Regardless of Their Signaling Profile. Int J Mol Sci 2020; 21(2): 512.
[http://dx.doi.org/10.3390/ijms21020512] [PMID: 31947522]
[53]
Mason PK, Malhotra R. Antidysrhythmic electrophysiology and pharmacology.Cardiac Intensive Care. 3rd ed. Philadelphia: Elsevier Health Sciences 2018; pp. 409-20.
[54]
Elshafei MN, Hussein WR, Shehata OM, et al. Perioperative beta-blocker and its effect on coronary artery bypass graft patient’s outcome after surgery. Ain-Shams J Anesthesiol 2020; 12: 31.
[http://dx.doi.org/10.1186/s42077-020-00079-6]
[55]
Lanza GA, De Vita A, Kaski JC. ‘Primary’ Microvascular Angina: Clinical Characteristics, Pathogenesis and Management. Interv Cardiol (Lond) 2018; 13(3): 108-11.
[http://dx.doi.org/10.15420/icr.2018.15.2] [PMID: 30443265]
[56]
Staloch D, El Chami M. Palpitations.Handbook of Inpatient Cardiology. 1st ed. Cham: Springer 2020; pp. 405-14.
[http://dx.doi.org/10.1007/978-3-030-47868-1_25]
[57]
Santucci A, Riccini C, Cavallini C. Treatment of stable ischaemic heart disease: the old and the new. Eur Heart J Suppl 2020; 22(Suppl. E): E54-9.
[http://dx.doi.org/10.1093/eurheartj/suaa060] [PMID: 32523440]
[58]
Setia S. Perioperative Medication Management.The Perioperative Medicine Consult Handbook. 3rd ed. Cham: Springer 2020; pp. 35-46.
[http://dx.doi.org/10.1007/978-3-030-19704-9_5]
[59]
Tran P, Banerjee P. Iatrogenic Decompensated Heart Failure. Curr Heart Fail Rep 2020; 17(2): 21-7.
[http://dx.doi.org/10.1007/s11897-020-00452-4] [PMID: 32086714]
[60]
Ge Y, Smits AM, van Munsteren JC, et al. Human epicardium-derived cells reinforce cardiac sympathetic innervation. J Mol Cell Cardiol 2020; 143: 26-37.
[http://dx.doi.org/10.1016/j.yjmcc.2020.04.006] [PMID: 32277975]
[61]
Shah AB, Bechis MZ, Brown M, et al. Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy. J Physiol 2019; 597(5): 1337-46.
[http://dx.doi.org/10.1113/JP277494] [PMID: 30552684]
[62]
Koracevic G. Significance of “Beta Blocker Rebound Phenomenon” and new suggestions how to avoid it. In: Rivas-Echeverria C, Allegaert K, Wainstein DE, Eds. Proceedings of the World Medical Conference. 2011 Sep 26-28; Prague, Czech Republic. 79-84.
[63]
Schonberger RB, Lukens CL, Turkoglu OD, Feinleib JL, Haspel KL, Burg MM. β-blocker withdrawal among patients presenting for surgery from home. J Cardiothorac Vasc Anesth 2012; 26(6): 1029-33.
[http://dx.doi.org/10.1053/j.jvca.2012.01.024] [PMID: 22418043]

Rights & Permissions Print Cite
Article Metrics
29
1
© 2024 Bentham Science Publishers | Privacy Policy